Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.57 |
| ▸ | GAA | P10253 | 1/20 | 0.57 |
| ▸ | CA1 | P00915 | 3/20 | 0.48 |
| ▸ | CA2 | P00918 | 3/20 | 0.48 |
| ▸ | CA12 | O43570 | 2/20 | 0.48 |
| ▸ | CA7 | P43166 | 2/20 | 0.48 |
| ▸ | CA9 | Q16790 | 2/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 3/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6231813 | 0.88 | ALDH1A1 (0.44) | ALDH1A1GAACA1CA2CA12 | |
| SCHEMBL799846 | 0.88 | ALDH1A1 (0.70) | ALDH1A1GAACA1CA2CA12 | |
| SCHEMBL28499495 | 0.86 | ALDH1A1 (0.58) | ALDH1A1GAACA1CA2CA12 | |
| SCHEMBL8902079 | 0.82 | ALDH1A1 (0.55) | ALDH1A1GAACA1CA2CA12 | |
| SCHEMBL30379901 | 0.81 | ALDH1A1 (0.54) | ALDH1A1GAACA1CA2CA12 | |
| SCHEMBL252044 | 0.81 | ALDH1A1 (0.54) | ALDH1A1GAACA1CA2CA12 | |
| SCHEMBL13019819 | 0.80 | CA12 (0.48) | ALDH1A1CA1CA2CA12CA7 | |
| SCHEMBL10843251 | 0.79 | GAA (0.53) | ALDH1A1GAACA1CA2CA12 | |
| SCHEMBL9017812 | 0.79 | ALDH1A1 (0.49) | ALDH1A1GAACA1CA2CA12 | |
| SCHEMBL9017810 | 0.79 | ALDH1A1 (0.52) | ALDH1A1GAACA1CA2CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9000220-B2 | Organophosphorus compounds based on tetraphenol (TP)-substituted structures | EVONIK DEGUSSA GMBH (DE) | 2015-04-07 | — | — | US | disclosed |
| US-20120197025-A1 | ORGANOPHOSPHORUS COMPOUNDS BASED ON TETRAPHENOL (TP)-SUBSTITUTED STRUCTURES | EVONIK OXENO GMBH (DE) | 2012-08-02 | — | — | US | disclosed |
| EP-2403657-A1 | PROCESS FOR PREPARING STRUCTURED ORGANIC FILMS (SOFS) VIA A PRE-SOF | Xerox Corporation (US) | 2012-01-11 | — | — | EP | disclosed |
| WO-2010102043-A1 | PROCESS FOR PREPARING STRUCTURED ORGANIC FILMS (SOFS) VIA A PRE-SOF | XEROX CORPORATION (US) | 2010-09-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120197025-A1 | ORGANOPHOSPHORUS COMPOUNDS BASED ON TETRAPHENOL (TP)-SUBSTITUTED STRUCTURES | PTMS, HPD, INPPL1 | ALDH1A1 4709/4885GAA 2995/4885CA1 397/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.